Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Deficient activities of multiple steroidogenic enzymes have been reported without and with Antley-Bixler syndrome (ABS), but mutations of corresponding cytochrome P450 enzymes have not been found. We identified mutations in POR, encoding P450 oxidoreductase, the obligate electron donor for these enzymes, in a woman with amenorrhea and three children with ABS, even though knock-out of POR is embryonically lethal in mice. Mutations of POR also affect drug-metabolizing P450 enzymes, explaining the association of ABS with maternal fluconazole ingestion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“POR is located in the endoplasmic reticulum of the cells, where it operates as an electron donor for the cytochromes P450, heme oxygenase, squalene monooxygenase, and other redox partners [2,3,4].”
From Loss of Protein Stability and Function Caused by P228L Variation in NADPH-Cytochrome P450 Reductase Linked to Lower Testosterone Levels (2022) · cites this paper as [3]
In the citing paper
“PORD manifests with a wide range of clinical signs and symptoms, and our study shows a broader phenotypic expression in Caucasian patients than previously observed in a large Japanese cohort (3, 7, 14, 15).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [3]
In the citing paper
“We previously demonstrated predominant 17α-hydroxylase over 21-hydroxylase impairment by p.A287P (21), and indeed, arterial hypertension has been documented in homozygous carriers (3, 12), probably caused by excess deoxycorticosterone production as in classical 17α-hydroxylase deficiency.”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [3]
In the citing paper
“Before our study only two p.A287P homozygous patients have been described; one with an unclear karyotype and genital appearance (7) and the other with ambiguous genitalia and 46,XY DSD (3).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [3]
In the citing paper
“Of note, the clinical presentation of PORD shows broad phenotypic variability, with adrenal insufficiency, DSD, and skeletal malformations present in some patients but not in others (3, 7, 15, 17).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [3]
24 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Wang, M., Roberts, D. L., Paschke, R., Shea, T. M., Masters, B. S. S., & Kim, J.-J. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8411 · Cited by 744
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Self-citationThe genetic and functional basis of isolated 17,20 lyase deficiency
Geller, D. H., Auchus, R. J., Mendonça, B. B., & Miller, W. L. (1997) · Nature Genetics · doi:10.1038/ng1097-201 · Cited by 318
Self-citationShen, A. L., O'Leary, K. A., & Kasper, C. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111408200 · Cited by 225
Otto, D. M. E., Henderson, C. J., Carrie, D., Davey, M., Gundersen, T. E., Blomhoff, R., Adams, R. H., Tickle, C., & Wolf, C. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6103-6116.2003 · Cited by 189
Auchus, R. J., & Miller, W. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.7.0326 · Cited by 185
Self-citationGeller, D. H., Auchus, R. J., & Miller, W. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.1.0219 · Cited by 183
Self-citationPeterson, R. E., Imperato-McGinley, J., Gautier, T., & Shackleton, C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511073131903 · Cited by 148
Evidence for digenic inheritance in some cases of Antley-Bixler syndrome?
Reardon, W., Smith, A., Honour, J. W., Hindmarsh, P., Das, D., Rumsby, G., Nelson, I., Malcolm, S., Adès, L., Sillence, D., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.1.26 · Cited by 123
Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia
Kelley, R. I., Kratz, L. E., Glaser, R. L., Netzloff, M. L., Miller Wolf, L., & Jabs, E. W. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10510 · Cited by 95
Self-citation
Research works printed but not linked: 2
- Miller, W.L. N. Engl. J. Med. 314, 1321–1322 (1986).
- Auchus, R.J. & Miller, W.L. Mol. Endocrinol. 13, 1169–1182 (1999).
Cited by
Items 201–300 of 509
Cytochromes P450—A Family of Proteins and Scientists–Understanding their Relationships
Masters, B. S. S., & Marohnic, C. C. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600570065 · Cited by 35
“In addition to the 5 mutations/polymorphisms originally reported (Flück et al., 2004), 11 new variants were discovered: A115V, T142A, Q153R, M263V, Y459H, A503V, G539R, L565P, R616X, V631l, and F646del.”
BackgroundInfluentialP450 oxidoreductase deficiency and Antley–Bixler syndrome
Arlt, W. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9056-y · Cited by 36
“However, recently American and British groups independently reported that this disease entity was caused by inactivating mutations in P450 oxidoreductase, a key electron donor enzyme providing electrons to all microsomal P450 (CYP) enzymes including the key enzymes in glucocorticoid and sex steroid synthesis, CYP17 an…”
BackgroundInfluentialSelf-citationFukami, M., Nagai, T., Mochizuki, H., Muroya, K., Yamada, G., Takitani, K., & Ogata, T. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.03.023 · Cited by 30
“sia referred to as Antley–Bixler syndrome, adrenal dysfunction, 46,XX and 46,XY disorders of sex development (DSD), and maternal virilization during pregnancy [2,3].”
P450 Oxidoreductase Deficiency: A New Disorder of Steroidogenesis
Miller, W. L., Huang, N., Pandey, A. V., Flück, C. E., & Agrawal, V. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1336.012 · Cited by 37
Self-citationIdkowiak, J., Malunowicz, E. M., Dhir, V., Reisch, N., Szarras-Czapnik, M., Holmes, D. M., Shackleton, C. H. L., Davies, J. D., Hughes, I. A., Krone, N., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0058 · Cited by 30
Self-citationModeling of human P450 oxidoreductase structure by in silico mutagenesis and MD simulation
Flück, C. E., Mullis, P. E., & Pandey, A. V. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.001 · Cited by 31
Self-citationWilliamson, L., Arlt, W., Shackleton, C., Kelley, R. I., & Braddock, S. R. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31385 · Cited by 30
“These mutations alter steroidogenesis [Kelley et al., 2002; Arlt et al., 2004; Fluck et al., 2004; Adachi et al., 2004b; Shackleton et al., 2004b; Fukami et al., 2005; Huang et al., 2005; Miller, 2005] by disrupting the ability of POR to transfer electrons from NADPH to 17-alpha-monooxygenase and…”
BackgroundResultInfluentialSelf-citationThe broad phenotypic spectrum of 17α-hydroxylase/17,20-lyase (CYP17A1) deficiency: a case series
Sun, M., Mueller, J. W., Gilligan, L. C., TAYLOR, A. E. R., Shaheen, F., Noczyńska, A., T'Sjoen, G. G., Denvir, L., Shenoy, S., Fulton, P., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0152 · Cited by 31
“Milder deficiencies can be compensated, as seen in patients 5–8.”
Self-citationHistory of Adrenal Research: From Ancient Anatomy to Contemporary Molecular Biology
Miller, W. L., & White, P. C. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac019 · Cited by 35
Self-citationClinical and molecular review of atypical congenital adrenal hyperplasia
Sahakitrungruang, T. (2015) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2015.20.1.1 · Cited by 30
Gonzalès, M., Heuertz, S., Martinovic, J., Delahaye, S., Bazin, A., Loget, P., Pasquier, L., Merrer, M. F. L., & Bonaventure, J. (2005) · Clinical Genetics · doi:10.1111/j.1399-0004.2005.00477.x · Cited by 32
“They could be used for differential clinical diagnosis as such anomalies have never been described in patients with AB syndrome caused by P450 Oxido Reductase (POR) mutations (16).”
BackgroundHigh-Yield Expression of a Catalytically Active Membrane-Bound Protein: Human P450 Oxidoreductase
Sandee, D., & Miller, W. L. (2011) · Endocrinology · doi:10.1210/en.2011-0230 · Cited by 29
“For example, the disease-causing mutant A287P has 20 – 40% of wild-type (WT) activity to support the 17 -hydroxylation and 17,20 lyase activity of P450c17 (4, 5) and 14 –”
BackgroundSelf-citationMiller, W. L. (2012) · Science Signaling · doi:10.1126/scisignal.2003318 · Cited by 34
“However, the A287P mutant found in a homozygously affected infant with severe ABS appeared to have about half of normal activity, whereas the C569Y and V608F mutants found in the mildly affected Brazilian woman appeared to have much less activity (12).”
BackgroundMethodInfluentialSelf-citationLi, Z., Chadalapaka, G., Ramesh, A., Khoshbouei, H., Maguire, M., Safe, S., Rhoades, R. E., Clark, R., Jules, G., McCallister, M., et al. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfr261 · Cited by 29
“Interestingly, additional phenotypes of the Cpr-low mouse have already been identified such as female infertility and an altered steroid homeostasis known to occur in human subjects (Artl et al., 2004; Fluck et al., 2004; Fukami et al., 2005, 2006; Huang et al., 2005).”
BackgroundMolecular Mechanisms Involved in Craniosynostosis
YAPIJAKIS, C., PACHIS, N., SOTIRIADOU, T., VAILA, C., MICHOPOULOU, V., & VASSILIOU, S. (2023) · In Vivo · doi:10.21873/invivo.13052 · Cited by 28
Parween, S., Fernández-Cancio, M., Benito-Sanz, S., Camats, N., Rojas Velazquez, M. N., López-Siguero, J.-P., Udhane, S. S., Kagawa, N., Flück, C. E., Audí, L., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa076 · Cited by 28
Self-citationClinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)
Ishii, T., Kashimada, K., Amano, N., Takasawa, K., Nakamura‐Utsunomiya, A., Yatsuga, S., Mukai, T., Ida, S., Isobe, M., Fukushi, M., et al. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0009 · Cited by 37
“The major concerns regarding 17-OHP levels are potentially elevated in other types of CAH compared to 21-OHD (11β-hydroxylase deficiency, 3β-hydroxysteroid dehydrogenase deficiency, and cytochrome P450 oxidoreductase deficiency) and falsely elevated because of cross-reactivity (57, 58).”
BackgroundSelf-citationKo, J. M., Cheon, C.-K., Kim, G.-H., & Yoo, H.-W. (2009) · European Journal of Pediatrics · doi:10.1007/s00431-008-0849-0 · Cited by 28
“POR deficiency thus results in congenital adrenal hyperplasia, which manifests as combined deficiencies of 17α-hydroxylase, 17,20-lyase, and 21-hydroxylase [4, 8 ]. In this case, inadequate cortisol and DHEA-sulfate responses to ACTH stimulation, and increased baseline levels of 17-OHP and ACTH, indicated compensated…”
BackgroundInfluentialThe Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Self-citationTargeted gene panel sequencing for molecular diagnosis of congenital adrenal hyperplasia
Wang, W., Han, R., Yang, Z., Zheng, S., Li, H., Wan, Z., Qi, Y., Sun, S., Ye, L., & Ning, G. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105899 · Cited by 27
Congenital Adrenal Hyperplasias Presenting in the Newborn and Young Infant
Balsamo, A., Baronio, F., Ortolano, R., Menabò, S., Baldazzi, L., Natale, V. D., Vissani, S., & Cassio, A. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.593315 · Cited by 30
“P450 Oxidoreductase Deficiency (POR-D) Epidemiology/Genetics POR-D was first described in 2004 (59) as a rare form of CAH.”
BackgroundTimberlake, A. T., McGee, S., Allington, G., Kiziltug, E., Wolfe, E. M., Stiegler, A. L., Boggon, T. J., Sanyoura, M., Morrow, M. M., Wenger, T. L., et al. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.03.017 · Cited by 30
Serafi, I. E., & Steele, S. (2024) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/2024/4862706 · Cited by 30
“Accord-ingly, POR defciency may lead to serious complications such as disordered steroidogenesis, abnormal genitalia, bone abnormalities, and William’s syndrome [77–79].”
Akhenaten and the Strange Physiques of Egypt's 18th Dynasty
Braverman, I. M., Redford, D. B., & Mackowiak, P. A. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-8-200904210-00010 · Cited by 26
“Although the syndrome was initially believed to be caused by mutations in the FGFR2 gene, Flu ¨ck and colleagues ( 27 ) recently reported that a mutation in the POR gene encoding P450 oxidoreductase is the actual defect responsible for the impaired steroidogenesis and craniofacial abnormalities.”
BackgroundArthrogryposes (Multiple Congenital Contractures)
Hall, J. G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00168-3 · Cited by 29
Velazquez, M. N. R., Parween, S., Udhane, S. S., & Pandey, A. V. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.127 · Cited by 31
Self-citationIntronic polymorphisms of cytochromes P450
Ingelman‐Sundberg, M., & Sim, S. C. (2010) · Human Genomics · doi:10.1186/1479-7364-4-6-402 · Cited by 27
Parween, S., Velazquez, M. N. R., Udhane, S. S., Kagawa, N., & Pandey, A. V. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01187 · Cited by 24
Self-citationRoles of retinoic acid signaling in normal and abnormal development of the palate and tongue
Okano, J., Udagawa, J., & Shiota, K. (2014) · Congenital Anomalies · doi:10.1111/cga.12049 · Cited by 25
“So far, two causative genes have been identified: electron donor enzyme P450 oxidoreductase (POR) and fibroblast growth factor receptor 2 (FGFR2) (Chun et al. 1998; Fluck et al. 2004; Fukami et al. 2005; Huang et al. 2005).”
BackgroundFlück, C. E., Yaworsky, D. C., & Miller, W. L. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.38404.x · Cited by 25
“The OHase and lyase activities of P450c17 require electron donation from P450 oxidoreductase (5,8), which is expressed by our engineered yeast system (5).”
BackgroundSelf-citationSteroidogenic electron-transfer factors and their diseases
Miller, W. L. (2021) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2142154.077 · Cited by 24
Self-citationSong, T., Wang, B., Chen, H., Zhu, J., & Sun, H. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1393663 · Cited by 24
“CYP19A1 activity, thus reducing steroid hormone synthesis [8,9].”
Thirty-Year Lessons from the Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in Japan
Tsuji‐Hosokawa, A., & Kashimada, K. (2021) · International Journal of Neonatal Screening · doi:10.3390/ijns7030036 · Cited by 34
Structural Genome Variations Related to Craniosynostosis
Poot, M. (2018) · Molecular Syndromology · doi:10.1159/000490480 · Cited by 28
Wudy, S. A., Hartmann, M. F., Draper, N., Stewart, P. M., & Arlt, W. (2004) · Endocrine Research · doi:10.1081/erc-200044174 · Cited by 24
Self-citationCaldas, H., Cunningham, D., Wang, X., Jiang, F., Humphries, L., Kelley, R. I., & Herman, G. E. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.08.007 · Cited by 25
Biason‐Lauber, A., Boscaro, M., Mantero, F., & Balercia, G. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346683 · Cited by 25
Prenatal Diagnosis of Antley-Bixler Syndrome and POR Deficiency
Oldani, E., Garel, C., Bucourt, M., & Carbillon, L. (2015) · American Journal of Case Reports · doi:10.12659/ajcr.895526 · Cited by 23
Biallelic mutations in CYP26B1 : A differential diagnosis for Pfeiffer and Antley–Bixler syndromes
Morton, J. E. V., Frentz, S., Morgan, T., Sutherland‐Smith, A. J., & Robertson, S. P. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37804 · Cited by 24
Genetic Disorders of Steroid Metabolism Diagnosed by Mass Spectrometry
Shackleton, C. H. L. (2008) · Springer eBooks · doi:10.1007/978-3-540-76698-8_26 · Cited by 26
Soneda, S., Yazawa, T., Fukami, M., Adachi, M., Mizota, M., Fujieda, K., Miyamoto, K., & Ogata, T. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1337 · Cited by 23
Self-citationRare forms of congenital adrenal hyperplasia
Tosun, B. G., & Güran, T. (2023) · Clinical Endocrinology · doi:10.1111/cen.15009 · Cited by 28
Fan, L., Ren, X., Song, Y., Su, C., Fu, J., & Gong, C. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1283-2 · Cited by 22
46,XY disorders of sex development (DSD)
Mendonca, B. B., Domenice, S., Arnhold, I. J. P., & Costa, E. M. F. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02993.x-i1 · Cited by 42
Burris‐Hiday, S. D., & Scott, E. E. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105112 · Cited by 22
Mast, N., Liao, W.-L., Pikuleva, I. A., & Turko, I. V. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.01.002 · Cited by 25
Molecular Diagnosis of Congenital Adrenal Hyperplasia in Iran: Focusing on CYP21A2 Gene.
Rabbani, B., Mahdieh, N., Haghi-Ashtiani, M. T., Akbari, M.-T., & Rabbani, A. (2011) · PubMed Central · Cited by 28
Marohnic, C. C., Huber, W. J., Connick, J. P., Reed, J. R., McCammon, K. M., Panda, S. P., Martasek, P., Backes, W. L., & Masters, B. S. S. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.06.008 · Cited by 27
Functional POR A503V is associated with the risk of bladder cancer in a Chinese population
Xiao, X., Ma, G., Li, S., Wang, M., Liu, N., Ma, L., Zhang, Z., Chu, H., Zhang, Z., & Wang, S. (2015) · Scientific Reports · doi:10.1038/srep11751 · Cited by 23
Haiman, C. A., Setiawan, V. W., Xia, L. Y., Marchand, L. L., Ingles, S. A., Ursin, G., Press, M. F., Bernstein, L., John, E. M., & Henderson, B. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4801 · Cited by 22
“www.aacrjournals.org 3565 Cancer Res 2007; 67: ( 8 ).”
BackgroundInfluentialCongenital Adrenal Hyperplasia—More Dogma Bites the Dust
Auchus, R. J., & Miller, W. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1080 · Cited by 22
Self-citationAguilar, A., Wu, S., & De Luca, F. (2009) · Endocrinology · doi:10.1210/en.2009-0043 · Cited by 21
“Furthermore, severe POR mutations cause skeletal malformations, whereas mild POR mutations are associated with normal skeletal development (13).”
BackgroundLeveraging AI to explore structural contexts of post-translational modifications in drug binding
Medvedev, K. E., Schaeffer, R. D., & Grishin, N. V. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-01019-y · Cited by 26
“Several mutations in this protein have been found to be related to the development of Antley-Bixler syndrome, which is characterized by structural abnormalities of skeletal systems [80].”
Pediatric Disorders of Sex Development
Achermann, J. C., & Hughes, I. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00023-x · Cited by 29
Pan, P., Zheng, L., Chen, X., Huang, J., Yang, D., & Li, Y. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00778-0 · Cited by 27
Shedding Light on Protein Folding, Structural and Functional Dynamics by Single Molecule Studies
Bavishi, K., & Hatzakis, N. S. (2014) · Molecules · doi:10.3390/molecules191219407 · Cited by 21
“diseased states ranging from cortisol deficiency to skeletal dysplasia [137–139].”
BackgroundYang, M., & White, P. C. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae535 · Cited by 20
The uncommon forms of congenital adrenal hyperplasia
Auchus, R. J. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000727 · Cited by 26
“Thus, PORD and 3bHSDD are the two forms of CAH that can cause genital ambiguity in both boys and girls.”
BackgroundInfluentialUdhane, S. S., & Flück, C. E. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.10.010 · Cited by 27
Self-citationStewart, P. M., & Newell-Price, J. D. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00015-0 · Cited by 34
Clinical Implications of Androgen Synthesis via 5&agr;-Reduced Precursors
Ghayee, H. K., & Auchus, R. J. (2008) · KARGER eBooks · doi:10.1159/000134780 · Cited by 23
Bonamichi, B. D. S. F., Santiago, S. L. M., Bertola, D. R., Kim, C. A., Alonso, N., Mendonca, B. B., Bachega, T. A. S. S., & Gomes, L. G. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000213 · Cited by 19
“Notably, high blood pressure due to increased DOCA and impairment of 17α-hydroxylase was reported (1).”
BackgroundInfluentialSelf-citationNovel SNPs in Cytochrome P450 Oxidoreductase
Hart, S. N., Li, Y., Nakamoto, K., Wesselman, C., & Zhong, X. (2007) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.22.322 · Cited by 20
Honour, J. W., Conway, E., Hodkinson, R., & Lam, F. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.02.013 · Cited by 20
“It has thus been appreciated in the case of cytochrome P450 oxidoreductase as a common electron transporter to 21 and 17 hydroxylases [285].”
BackgroundThe Basis of Gender Assignment in Disorders of Somatosexual Differentiation
Hiort, O., Thyen, U., & Holterhus, P. (2005) · Hormone Research in Paediatrics · doi:10.1159/000087748 · Cited by 19
“supports the potential role of genetic factors in normal and abnormal development of the human genital anlagen.Much more is known about disorders affecting steroid biosynthesis or action, termed disorders of sexual differentiation. Steroid synthesis was thought for some time to have been completely elucidated; however…”
ResultGuaragna-Filho, G., Castro, C. C. T. D. S., De Carvalho, R. R., Coeli, F. B., Ferraz, L. F. C., Petroli, R. J., De Mello, M. P., Sewaybricker, L. E., Lemos-Marini, S. H. V., D'Souza-Li, L. F. R., et al. (2012) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302012000800020 · Cited by 18
“Ovarian cysts are a common finding in females affected by steroidogenic disorders, have been reported in deficiencies of CYP21A2 (26), CYP17A1 (27), STAR (28), CYP19A1 (29) and, recently, in POR deficiency (14,18,30).”
BackgroundInfluentialArboleda, V. A., Fleming, A. A., & Vilain, E. J. N. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374430-2.00021-3 · Cited by 20
Defects of Adrenal Steroidogenesis
Yau, M., Khattab, A., Pina, C., Yuen, T., Meyer‐Bahlburg, H. F. L., & New, M. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00104-9 · Cited by 20
Alberola, T. M., Bautista-Llácer, R., Fernández, E., Vendrell, X., & Pérez‐Alonso, M. (2009) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-009-9327-5 · Cited by 18
“Approximately 40 cases have been reported since the first mutations were described in 2004 [9].”
BackgroundBioactivity of curcumin on the cytochrome P450 enzymes of the steroidogenic pathwayPreprint
Castaño, P. R., Parween, S., & Pandey, A. V. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/669440 · Cited by 19
Self-citationNon-traditional metabolic pathways of adrenal steroids
Auchus, R. J. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9095-z · Cited by 17
Zhang, T., Li, Z., Ren, X., Huang, B., Zhu, G., Yang, W., & Jin, L. (2020) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-020-01899-z · Cited by 24
“However, no patients with two apparently null mutations have been reported so far, indicating a complete loss of POR function might be incompatible with life [12, 13].”
BackgroundTomková, M., Marohnic, C. C., Gurwitz, D., Šeda, O., Masters, B. S. S., & Martásek, P. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.21 · Cited by 17
An overview of inborn errors of metabolism manifesting with primary adrenal insufficiency
Hannah‐Shmouni, F., & Stratakis, C. A. (2018) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-018-9447-2 · Cited by 18
“P450 oxidoreductase (POR) deficiency POR • 46,XX and 46,XY ambiguous genitalia, PAI, severe salt-wasting, possible maternal virilization during pregnancy.”
BackgroundInfluentialFang, Y., Gao, N., Tian, X., Zhou, J., Zhang, H., Gao, J., He, X.-P., Wen, Q., Jia, L.-J., Jin, H., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000490934 · Cited by 19
Ferroptosis-Related Flavoproteins: Their Function and Stability
Vabulas, R. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010430 · Cited by 17
“This assumption proved true by the first molecular description of the clinical POR deficiencies that had manifested in the combined insufficiency of 17α-hydroxylase and 21-hydroxylase [63].”
BackgroundCytochrome P450 oxidoreductase deficiency with Antley-Bixler syndrome: Steroidogenic capacities
Iijima, S., Ohishi, A., & Ohzeki, T. (2009) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2009.22.5.469 · Cited by 16
Disordered Electron Transfer: New Forms of Defective Steroidogenesis and Mitochondriopathy
Miller, W. L., Pandey, A. V., & Flück, C. E. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae815 · Cited by 17
Self-citationLee, Y., Choi, J.-H., Oh, A., Kim, G.-H., Park, S.-H., Moon, J. E., Ko, C. W., Cheon, C.-K., & Yoo, H.-W. (2020) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.1938152.076 · Cited by 16
Radiographic features of the skeleton in disorders of post-squalene cholesterol biosynthesis
Rossi, M., Hall, C. M., Bouvier, R., Collardeau‐Frachon, S., Breton, F. L., Bucourt, M., Cordier, M. P., Vianey‐Saban, C., Parenti, G., Andria, G., et al. (2015) · Pediatric Radiology · doi:10.1007/s00247-014-3257-9 · Cited by 19
“This condition is caused by mutations of the POR gene, coding for a cytochrome P450 oxidoreductase [42, 43].”
BackgroundWei, Y., Zhou, X., Fang, C., Li, L., Kluetzman, K., Yang, W., Zhang, Q.-Y., & Ding, X. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167411 · Cited by 17
“…for P450 oxidoreductase), and many mutant POR alleles have been found to be associated with congenital deficiencies in steroidogenesis/homeostasis and/or with Antley Bixler syndrome, characterized by skeletal malformation and reproductive defects (e.g., Flück et al., 2004; Fukami et al., 2005).”
BackgroundArthrogryposes (Multiple Congenital Contractures)
Hall, J. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.05632-4 · Cited by 16
Frisso, G., Gelzo, M., Procopio, E., Sica, C., Lenza, M. P., Russo, A. D., Donati, M. A., Salvatore, F., & Corso, G. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2017.06.013 · Cited by 16
Rénier, D., Merrer, M. F. L., Arnaud, É., & Marchac, D. (2006) · Neurochirurgie · doi:10.1016/s0028-3770(06)71217-6 · Cited by 17
King Tutankhamun’s Family and Demise
Lorenzen, E. D. (2010) · JAMA · doi:10.1001/jama.2010.818 · Cited by 16
“Heterozygous and homozygous HbS carriers are not protected from P falciparum infection per se and may exhibit significant parasitemia.(4,5) However, although heterozygous carriers are protected from severe courses of falciparum malaria, homozygous carriers are prone to childhood or early adulthood fatality from SCD an…”
BackgroundInfluentialFlück, C. E., Parween, S., Rojas Velazquez, M. N., & Pandey, A. V. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003154117 · Cited by 15
Self-citationGusmano, C., Cannarella, R., Crafa, A., Barbagallo, F., Vignera, S. L., Condorelli, R. A., & Calogero, A. E. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01849-9 · Cited by 21
Gocek, E., Marchwicka, A., Bujko, K., & Marcinkowska, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091752 · Cited by 16
“Williams syndromes [25,26,27].”
Potential Biological Functions of Cytochrome P450 Reductase-dependent Enzymes in Small Intestine
D’Agostino, J., Ding, X., Zhang, P., Jia, K., Fang, C., Zhu, Y., Spink, D. C., & Zhang, Q.-Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.354274 · Cited by 16
“In humans, mutations in the POR gene result in disordered steroidogenesis and the Antley-Bixler syndrome (5).”
BackgroundSchulz, C., Kammerer, S., & Küpper, J. (2019) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-199226 · Cited by 18
“Genetically-caused POR deficiency in vivo can lead to dysfunctions in steroid genesis, ambiguous genitalia and Antley-Bixler syndrome [40, 41].”
BackgroundNakamura, T., Fukuda, M., Matsukane, R., Suetsugu, K., Harada, N., Yoshizumi, T., Egashira, N., Mori, M., & Masuda, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072287 · Cited by 18
“Gene mutations in POR range from rare ones that cause bone malformations, steroid synthesis disorders, and genital lesions [17,18] to more common ones, with a high frequency of expression.”
BackgroundCapra, V., Marco, P. D., Merello, E., Baffico, A. M., Baldi, M., Divizia, M. T., Gimelli, S., Mallet, D., Raso, A., Mascelli, S., et al. (2008) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2008.10.005 · Cited by 15
“The complete sequencing of both FGFR2 and POR (P450 cytochrome oxidoreductase participating in cholesterol biosynthesis) genes did not reveal any changes, so Pfeiffer and Antley– Bixler syndromes were excluded both clinically and genetically [4,5,10].”
BackgroundNovel methods in adrenal research: a metabolomics approach
Papathomas, T. G., Sun, N., Chortis, V., Taylor, A. E., Arlt, W., Richter, S., Eisenhofer, G., Ruiz-Babot, G., Guasti, L., & Walch, A. K. (2019) · Histochemistry and Cell Biology · doi:10.1007/s00418-019-01772-w · Cited by 14
Self-citationBiological Application and Disease of Oxidoreductase Enzymes
Habte, M. L., & Beyene, E. A. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.93328 · Cited by 14
The Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 35
Self-citationPanda, S. P., Guntur, A. R., Polusani, S. R., Fajardo, R. J., Gakunga, P. T., Roman, L. J., & Masters, B. S. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075638 · Cited by 14
“Indeed, certain mutations in the POR gene in the human population are accompanied with defective skeletal development similar to that of the previously described Antley-Bixler syndrome (ABS) [10], as well as aberrant steroid metabolism and ambiguous genitalia [11].”
ResultOvarian and Adrenal Androgen Biosynthesis and Metabolism
Miller, W. L., Geller, D. H., & Rosen, M. P. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_2 · Cited by 19
“presented with PCOS (36); whether this is a rare event or indicates that POR may be more commonly associated with some forms of PCOS is not yet known.”
BackgroundInfluentialSelf-citationCorso, G., Russo, A. D., & Gelzo, M. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i29.5257 · Cited by 16
Hao, C., Guo, J., Guo, R., Qi, Z., Li, W., & Ni, X. (2018) · Pediatric Investigation · doi:10.1002/ped4.12035 · Cited by 13
“However, mutations in cytochrome P450 oxidoreductase (POR) were identified as the cause of ABS with genital anomalies and disordered steroidogenesis.(4,5) These mutations affect steroidogenesis by disrupting the ability of POR to transfer electrons from nicotinamide a d e n i n e d i n u c l e o t i d e p h o s p h a…”
BackgroundVelazquez, M. N. R., Therkelsen, S., & Pandey, A. V. (2023) · Biomolecules · doi:10.3390/biom13121728 · Cited by 13
“The selection of control variants involved an exhaustive review of the existing literature to identify POR gene variants with well-documented experimental data [7,10–16 , 31 ].”
BackgroundSelf-citation
Metadata
- Authors
- Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L.
- Affiliations
- University of California, San Francisco (US)
- Hokkaido University (JP)
- Sydney Children's Hospital (AU)
- Johns Hopkins University (US)
- Asahikawa Medical University (JP)
- Corresponding author
- Miller, Walter L
- Venue
- Nature Genetics
- Published
- 2004-02-01
- Volume
- 36
- Issue
- 3
- Pages
- 228-230
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1988067304
- Semantic Scholar
- de46a6781c9fe47ed0dcc705d3a243d3ba41bef5
- Cited by
- 509
- References
- 14
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 16 · 2023: 15 · 2022: 14 · 2021: 20 · 2020: 26 · 2019: 27 · 2018: 15 · 2017: 24 · 2016: 22 · 2015: 24 · 2014: 19 · 2013: 28 · 2012: 21
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- National Research Foundation
- Deutsche Forschungsgemeinschaft
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- Antley-Bixler syndrome, cytochrome P450 oxidoreductase, POR gene, steroidogenesis disorders, amenorrhea, fluconazole, drug metabolism, congenital disorders of sex development
- MeSH terms
- Craniosynostoses, Female, Humans, Ketone Oxidoreductases, Mutation, NADPH-Ferrihemoprotein Reductase, Gonadal Steroid Hormones, Syndrome, Synostosis, Pyruvate Synthase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.